Results 11 to 20 of about 68,532 (268)
LESS IS MORE: classified management of hypertriglyceridemia-induced acute pancreatitis on the basis of a propensity score matching cohort study [PDF]
Lipids in Health and DiseaseBackground Effective management of hypertriglyceridemia is crucial in the treatment of hypertriglyceridemia-induced acute pancreatitis (HTG-AP). The prognosis of HTG-AP may vary with different serum triglyceride levels, suggesting the need for stratified
Pan Tan +7 more
doaj +2 more sources
Mechanisms linking hypertriglyceridemia to acute pancreatitis
Acta Physiologica, 2023 Hypertriglyceridemia (HTG) is a metabolic disorder, defined when serum or plasma triglyceride concentration (seTG) is >1.7 mM. HTG can be categorized as mild to very severe groups based on the seTG value.
L. Kiss +6 more
semanticscholar +1 more source
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial
Nature Network Boston, 2023 Pegozafermin, a long-acting glycopegylated analog of human fibroblast growth factor 21, is in development for the treatment of severe hypertriglyceridemia (SHTG) and nonalcoholic steatohepatitis.
D. Bhatt +13 more
semanticscholar +1 more source
Nutrients, 2013 Hypertriglyceridemia (HTG) is commonly encountered in lipid and cardiology clinics. Severe HTG warrants treatment because of the associated increased risk of acute pancreatitis. However, the need to treat, and the correct treatment approach for patients with mild to moderate HTG are issues for ongoing evaluation.
Brahm, Amanda, Hegele, Robert A.
openaire +2 more sources
Updates in Drug Treatment of Severe Hypertriglyceridemia
Current Atherosclerosis Reports, 2023 Purpose of Review To provide an insight into the new pharmacological options for the treatment of severe hypertriglyceridemia (sHTG). Recent Findings sHTG is difficult to treat.
I. Gouni-Berthold +2 more
semanticscholar +1 more source
Frontiers in Genetics, 2021 Transient infantile hypertriglyceridemia is a rare autosomal recessive disorder characterized by hypertriglyceridemia, hypohepatia, hepatomegaly, hepatic steatosis and fibrosis in infancy.
Haihua Lin +5 more
doaj +1 more source
Hepatology, EarlyView., 2022 Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou +13 more
wiley +1 more source
Mìžnarodnij Endokrinologìčnij Žurnal, 2020 Hypertriglyceridemia is defined as a value of fasting serum triglyceride over 150 mg/dl. The classification of hypertriglyceridemia according to the Endocrine Society includes mild and moderate hypertriglyceridemia, severe hypertriglyceridemia and very ...
E. Xhardo, F. Agaçi
doaj +1 more source
Journal of Infection in Developing Countries, 2022 Introduction: The objective of this study was to investigate changes in serum lipids among HIV-infected patients switching from non-nucleoside-reverse transcriptase inhibitors (NNRTI) to protease inhibitor (PI)-based highly active antiretroviral therapy
Yu Zhang +8 more
doaj +1 more source
The Journal of the American Board of Family Medicine, 2006 Hypertriglyceridemia is a commonly encountered lipid abnormality frequently associated with other lipid and metabolic derangements. The National Cholesterol Education Program recommends obtaining a fasting lipid panel in adults over the age of 20. The discovery of hypertriglyceridemia should prompt an investigation for secondary causes such as high fat
Rade N, Pejic, Daniel T, Lee
openaire +2 more sources